Capitalism goes rogue with patent claims on psychedelics
Neither Ekaterina Malievskaia (of COMPASS) nor Christian Angermayer (of ATAI) have succeeded so far in convincing other actors in the psychedelic field that Compass has not put its commercial interests and revenue projections before public health benefits and research freedom. This why Rick Doblin (of MAPS) reacted by tweeting: “Attempts to patent therapeutic methods invented…
Recent Comments